Sodium-glucose cotransporter 2 inhibitors in chronic kidney disease: A review of current evidence and clinical implications

Background: Chronic kidney disease (CKD) is a progressive condition affecting millions worldwide, leading to substantial morbidity, mortality, and healthcare burden. While traditional treatments such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) have been...

Full description

Saved in:
Bibliographic Details
Main Author: Abdulrahman Saad Alfaiz
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Endocrine and Metabolic Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666396125000378
Tags: Add Tag
No Tags, Be the first to tag this record!